1,5-Pentanediol

1,5-Pentanediol

SCHEMBL9614570

CC(O)CO.OCCCCCO

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of 1,5-Pentanediol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.67
TSHR P16473 4/20 0.47
LMNA P02545 4/20 0.47
ALDH1A1 P00352 4/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.42
GPR84 Q9NQS5 1/20 0.35
FFAR1 O14842 1/20 0.35
FFAR4 Q5NUL3 1/20 0.35
TRPV1 Q8NER1 1/20 0.33
KDM4E B2RXH2 1/20 0.33
THRB P10828 1/20 0.33
TRPA1 O75762 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,6-Hexanediol SCHEMBL10442947 1.00 TDP1 (0.67) TDP1TSHRLMNAALDH1A1HSD17B10
1,6-Hexanediol SCHEMBL3855738 1.00 TDP1 (0.67) TDP1TSHRLMNAALDH1A1HSD17B10
1,6-Hexanediol SCHEMBL27408868 1.00 TDP1 (0.67) TDP1TSHRLMNAALDH1A1HSD17B10
1,5-Pentanediol SCHEMBL9343564 1.00 TDP1 (0.67) TDP1TSHRLMNAALDH1A1HSD17B10
1,4-Butanediol SCHEMBL531424 0.97 TDP1 (0.71) TDP1TSHRLMNAALDH1A1HSD17B10
1,4-Butanediol SCHEMBL27302584 0.97 TDP1 (0.71) TDP1TSHRLMNAALDH1A1HSD17B10
1,4-Butanediol SCHEMBL28655257 0.97 TDP1 (0.71) TDP1TSHRLMNAALDH1A1HSD17B10
1,6-Hexanediol SCHEMBL28117808 0.94 TDP1 (0.59) TDP1TSHRLMNAALDH1A1HSD17B10
1,4-Butanediol SCHEMBL11103432 0.93 TDP1 (0.67) TDP1TSHRLMNAALDH1A1HSD17B10
1,4-Butanediol SCHEMBL19856450 0.93 TDP1 (0.67) TDP1TSHRLMNAALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014195004-A1 NERAMEXANE SALTS MERZ PHARMA GMBH & CO. KGAA (DE) 2014-12-11 WO disclosed
EP-0479850-A1 PREPARATION FOR TOPICAL TREATMENT OF INFECTIONS CAUSED BY VIRUS, BACTERIA AND FUNGI. SWANBECK GUNNAR (SE) 1992-04-15 EP disclosed
WO-1990015597-A1 PREPARATION FOR TOPICAL TREATMENT OF INFECTIONS CAUSED BY VIRUS, BACTERIA AND FUNGI SWANBECK GUNNAR (SE) 1990-12-27 WO disclosed